RT Journal Article
SR Electronic
T1 Mental health during the COVID-19 pandemic in two longitudinal UK population cohorts
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.06.16.20133116
DO 10.1101/2020.06.16.20133116
A1 Kwong, Alex S. F.
A1 Pearson, Rebecca M.
A1 Adams, Mark J.
A1 Northstone, Kate
A1 Tilling, Kate
A1 Smith, Daniel
A1 Fawns-Ritchie, Chloe
A1 Bould, Helen
A1 Warne, Naomi
A1 Zammit, Stan
A1 Gunnell, David
A1 Moran, Paul
A1 Micali, Nadia
A1 Reichenberg, Abraham
A1 Hickman, Matthew
A1 Rai, Dheeraj
A1 Haworth, Simon
A1 Campbell, Archie
A1 Altschul, Drew
A1 Flaig, Robin
A1 McIntosh, Andrew M.
A1 Lawlor, Deborah A.
A1 Porteous, David
A1 Timpson, Nicholas J.
YR 2020
UL http://medrxiv.org/content/early/2020/06/18/2020.06.16.20133116.abstract
AB Background The impact of COVID-19 on mental health is unclear. Evidence from longitudinal studies with pre pandemic data are needed to address (1) how mental health has changed from pre-pandemic levels to during the COVID-19 pandemic and (2), whether there are groups at greater risk of poorer mental health during the pandemic?Methods We used data from COVID-19 surveys (completed through April/May 2020), nested within two large longitudinal population cohorts with harmonised measures of mental health: two generations of the Avon Longitudinal Study of Parents and Children (ALPSAC): the index generation ALSPAC-G1 (n= 2850, mean age 28) and the parent’s generation ALSPAC-G0 (n= 3720, mean age = 59) and Generation Scotland: Scottish Family Health Study (GS, (n= 4233, mean age = 59), both with validated pre-pandemic measures of mental health and baseline factors. To answer question 1, we used ALSPAC-G1, which has identical mental health measures before and during the pandemic. Question 2 was addressed using both studies, using pre-pandemic and COVID-19 specific factors to explore associations with depression and anxiety in COVID-19.Findings In ALSPAC-G1 there was evidence that anxiety and lower wellbeing, but not depression, had increased in COVID-19 from pre-pandemic assessments. The percentage of individuals with probable anxiety disorder was almost double during COVID-19: 24% (95% CI 23%, 26%) compared to pre-pandemic levels (13%, 95% CI 12%, 14%), with clinically relevant effect sizes. In both ALSPAC and GS, depression and anxiety were greater in younger populations, women, those with pre-existing mental and physical health conditions, those living alone and in socio-economic adversity. We did not detect evidence for elevated risk in key workers or health care workers.Interpretation These results suggest increases in anxiety and lower wellbeing that may be related to the COVID-19 pandemic and/or its management, particularly in young people. This research highlights that specific groups may be disproportionally at risk of elevated levels of depression and anxiety during COVID-19 and supports recent calls for increasing funds for mental health services.Funding The UK Medical Research Council (MRC), the Wellcome Trust and University of Bristol.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe UK Medical Research Council and Wellcome (Grant Ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. ASFK, RMP, KT, DS, SH, DAL, NJT work in or are affiliated to the MRC Integrative Epidemiology Unit which is funded by the University of Bristol and UK Medical Research Council (MC_UU_00011/3 and MC_UU_00011/6). European Research Council under the European Unions Seventh Framework Programme, and grants 758813, MHINT and 669545 from the European Research Council Grant Agreements. This work was supported by Wellcome through the Wellcome Longitudinal Population Studies COVID-19 Secretariat and Steering Group (UK LPS COVID co-ordination, Grant Ref: 221574/Z/20/Z). This work was also supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust and the University of Bristol. Generation Scotland received core support from the Chief Scientist Office of the Scottish Government Health Directorates [CZD/16/6] and the Scottish Funding Council [HR03006], and is currently supported by the Wellcome Trust [216767/Z/19/Z]. Genotyping of the GS:SFHS samples was carried out by the Genetics Core Laboratory at the Wellcome Trust Clinical Research Facility, University of Edinburgh, Scotland, funded by the MRC and Wellcome Trust [104036/Z/14/Z]. This work has made use of the resources provided by the Edinburgh Compute and Data Facility (ECDF) (http://www.ecdf.ed.ac.uk/). NJT is a Wellcome Trust Investigator (202802/Z/16/Z), is the PI of the Avon Longitudinal Study of Parents and Children (MRC & WT 217065/Z/19/Z), is supported by the University of Bristol NIHR Biomedical Research Centre (BRC-1215-2001), the MRC Integrative Epidemiology Unit (MC_UU_00011) and works within the CRUK Integrative Cancer Epidemiology Programme (C18281/A19169). DG, PM, SZ and DR are supported by the NIHR Biomedical Research Centre at University Hospitals Bristol NHS Foundation Trust.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees and NHS Tayside Committee on Medical Research Ethics (reference 05/S1401/89).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesALSPAC data is available to researchers through an online proposal system. Information regarding access can be found on the ALSPAC website (http://www.bristol.ac.uk/media-library/sites/alspac/documents/researchers/data-access/ALSPAC_Access_Policy.pdf). GS:SFHS data is available to researchers on application to the Generation Scotland Access Committee (access@generationscotland.org). The managed access process ensures that approval is granted only to research which comes under the terms of participant consent.